AU5123396A - Pharmaceutical composition containing sucralfate - Google Patents
Pharmaceutical composition containing sucralfateInfo
- Publication number
- AU5123396A AU5123396A AU51233/96A AU5123396A AU5123396A AU 5123396 A AU5123396 A AU 5123396A AU 51233/96 A AU51233/96 A AU 51233/96A AU 5123396 A AU5123396 A AU 5123396A AU 5123396 A AU5123396 A AU 5123396A
- Authority
- AU
- Australia
- Prior art keywords
- pharmaceutical composition
- composition containing
- containing sucralfate
- sucralfate
- pharmaceutical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7024—Esters of saccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP7-77781 | 1995-04-03 | ||
JP7778195 | 1995-04-03 | ||
PCT/JP1996/000891 WO1996031218A1 (en) | 1995-04-03 | 1996-04-02 | Pharmaceutical composition containing sucralfate |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU11353/00A Division AU746091B2 (en) | 1995-04-03 | 2000-01-14 | Sucralfate containing pharmaceutical composition |
Publications (1)
Publication Number | Publication Date |
---|---|
AU5123396A true AU5123396A (en) | 1996-10-23 |
Family
ID=13643518
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU51233/96A Abandoned AU5123396A (en) | 1995-04-03 | 1996-04-02 | Pharmaceutical composition containing sucralfate |
Country Status (8)
Country | Link |
---|---|
US (1) | US5985843A (en) |
EP (1) | EP0823255A4 (en) |
KR (1) | KR19980703526A (en) |
CN (1) | CN1183044A (en) |
AU (1) | AU5123396A (en) |
CA (1) | CA2217233A1 (en) |
TR (1) | TR199701092T1 (en) |
WO (1) | WO1996031218A1 (en) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5698210A (en) | 1995-03-17 | 1997-12-16 | Lee County Mosquito Control District | Controlled delivery compositions and processes for treating organisms in a column of water or on land |
AU746091B2 (en) * | 1995-04-03 | 2002-04-18 | Chugai Seiyaku Kabushiki Kaisha | Sucralfate containing pharmaceutical composition |
US6077539A (en) | 1996-11-12 | 2000-06-20 | Pozen, Inc. | Treatment of migraine headache |
US6761895B2 (en) | 2000-04-17 | 2004-07-13 | Yamanouchi Pharmaceutical Co., Ltd. | Drug delivery system for averting pharmacokinetic drug interaction and method thereof |
JPWO2001078681A1 (en) * | 2000-04-17 | 2004-01-08 | 山之内製薬株式会社 | Drug delivery system and method for avoiding pharmacokinetic drug interaction |
WO2002064120A1 (en) * | 2001-02-13 | 2002-08-22 | Taisho Pharmaceutical Co., Ltd. | Gel preparations for internal use |
FR2822378A1 (en) * | 2001-03-23 | 2002-09-27 | Igen Ipsor Generiques | New preparation method of two layer tablets comprises separate compression of two powders, one giving instant liberation and the other giving prolonged liberation of active material, e.g. nicardipine for the treatment of hypertension |
US7985422B2 (en) * | 2002-08-05 | 2011-07-26 | Torrent Pharmaceuticals Limited | Dosage form |
US20050137262A1 (en) * | 2003-12-22 | 2005-06-23 | Hu Patrick C. | Highly concentrated pourable aqueous solutions of potassium ibuprofen, their preparation and their uses |
KR100582347B1 (en) * | 2004-12-30 | 2006-05-22 | 한미약품 주식회사 | Complex composition of 3-hydroxy-3-methyl glutaryl coa reductase inhibitor and antihypertensive agent, and process for preparing same |
US20060183725A1 (en) * | 2005-02-15 | 2006-08-17 | Thomas Graeser | Pharmaceutical preparation for oral contraception |
EP2063873A2 (en) * | 2006-08-31 | 2009-06-03 | Horizon Therapeutics, Inc. | Nsaid dose unit formulations with h2-receptor antagonists and methods of use |
CN102036656A (en) * | 2008-03-21 | 2011-04-27 | 米兰制药有限公司 | Extended release forumulation containing a wax |
BRPI0917206B1 (en) * | 2008-07-31 | 2018-04-17 | Clarke Mosquito Control Products, Inc. | METHOD FOR THE FORMATION OF A DOUBLE RELEASED TABLET, TABLETS AND METHOD FOR THE MANUFACTURE OF AN EXTENDED SOLID MATRIX |
EP2590634B1 (en) * | 2010-07-09 | 2016-03-09 | BHV Pharma, Inc. | Combination immediate/delayed release delivery system for short half-life pharmaceuticals including remogliflozin |
MX2013001278A (en) * | 2013-01-31 | 2014-07-30 | Miguel Ángel García Pérez | Pharmaceutical composition comprising a biphasic immediate-release system for controlling convulsive seizures and pain. |
GR1008308B (en) | 2013-05-31 | 2014-10-02 | UNI-PHARMA ΚΛΕΩΝ ΤΣΕΤΗΣ ΦΑΡΜΑΚΕΥΤΙΚΑ ΕΡΓΑΣΤΗΡΙΑ ΑΒΕΕ με δ.τ. "UNI-PHARMA ABEE", | Local pharmaceutical and medi-tech compositions containing combinations of sucralfat, hyaluronic acid, arginine and one natural moistening factor |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2347531A1 (en) * | 1973-09-21 | 1975-04-30 | Hoechst Ag | MEDICINAL PREPARATIONS FOR ORAL DIABETES TREATMENT |
JPS5978116A (en) * | 1982-10-27 | 1984-05-04 | Chugai Pharmaceut Co Ltd | Pharmaceutical preparation of sucralfate |
CA1218601A (en) * | 1983-09-02 | 1987-03-03 | Angel B. Casillan | Sucralfate suspension |
IT1201136B (en) * | 1987-01-13 | 1989-01-27 | Resa Farma | TABLET FOR PHARMACEUTICAL USE SUITABLE FOR THE RELEASE OF SUBSTANCES OF ACTIVE SUBSTANCES |
CN1053570C (en) * | 1987-10-07 | 2000-06-21 | 默尔多药物公司 | Pharmaceutical composition for piperidinoalkanol-decongestant combination |
US5032406A (en) * | 1989-02-21 | 1991-07-16 | Norwich Eaton Pharmaceuticals, Inc. | Dual-action tablet |
EP0403048A3 (en) * | 1989-06-14 | 1991-01-30 | Warner-Lambert Company | Medicated compositions containing sucralfate and processes for their production |
JP2907299B2 (en) * | 1989-09-07 | 1999-06-21 | ゲルゲリイ、ゲルハルト | Pharmaceutical preparations that bind stomach acid |
DK469989D0 (en) * | 1989-09-22 | 1989-09-22 | Bukh Meditec | PHARMACEUTICAL PREPARATION |
US5013557A (en) * | 1989-10-03 | 1991-05-07 | Warner-Lambert Company | Taste masking compositions comprising spray dried microcapsules containing sucralfate and methods for preparing same |
FR2655266B1 (en) * | 1989-12-05 | 1992-04-03 | Smith Kline French Lab | CIMETIDINE PHARMACEUTICAL COMPOSITIONS. |
GB9025710D0 (en) * | 1990-11-27 | 1991-01-09 | Beecham Group Plc | Novel treatment |
ATE112159T1 (en) * | 1991-01-30 | 1994-10-15 | Alza Corp | OSMOTIC DEVICE FOR DELAYED RELEASE OF AN ACTIVE SUBSTANCE. |
DE69231281T2 (en) * | 1991-12-17 | 2001-03-01 | Biovail Technologies Ltd.(N.D.Ges.D.Staates Delaware), Chantilly | COMPOSITION AND METHOD FOR ULCUS PREVENTION AND TREATMENT |
IT1255522B (en) * | 1992-09-24 | 1995-11-09 | Ubaldo Conte | COMPRESSED FOR THERAPEUTIC USE SUITABLE FOR SELLING ONE OR MORE ACTIVE SUBSTANCES WITH DIFFERENT SPEEDS |
AU7322394A (en) * | 1993-07-06 | 1995-02-06 | Mcneil-Ppc, Inc. | H2 antagonist-sucralfate-antiflatulent combinations |
US5593696A (en) * | 1994-11-21 | 1997-01-14 | Mcneil-Ppc, Inc. | Stabilized composition of famotidine and sucralfate for treatment of gastrointestinal disorders |
-
1996
- 1996-04-02 CA CA002217233A patent/CA2217233A1/en not_active Abandoned
- 1996-04-02 TR TR97/01092T patent/TR199701092T1/en unknown
- 1996-04-02 WO PCT/JP1996/000891 patent/WO1996031218A1/en not_active Application Discontinuation
- 1996-04-02 AU AU51233/96A patent/AU5123396A/en not_active Abandoned
- 1996-04-02 EP EP96907749A patent/EP0823255A4/en not_active Withdrawn
- 1996-04-02 CN CN96193604A patent/CN1183044A/en active Pending
- 1996-04-02 KR KR1019970706930A patent/KR19980703526A/en not_active Application Discontinuation
- 1996-04-02 US US08/930,263 patent/US5985843A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN1183044A (en) | 1998-05-27 |
EP0823255A4 (en) | 1999-01-27 |
WO1996031218A1 (en) | 1996-10-10 |
TR199701092T1 (en) | 1998-01-21 |
US5985843A (en) | 1999-11-16 |
KR19980703526A (en) | 1998-11-05 |
CA2217233A1 (en) | 1996-10-10 |
EP0823255A1 (en) | 1998-02-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP9802999A3 (en) | Pharmaceutical composition containing n-propargyl-1-aminoindan | |
AU6216296A (en) | Pharmaceutical compositions | |
HUP9602056A3 (en) | Novel pharmaceutical composition containing phenofibrate | |
HU9601698D0 (en) | Pharmaceutical composition | |
AUPN411195A0 (en) | Medicinal composition | |
AU7590096A (en) | Drug composition | |
AU6418596A (en) | Compounds and pharmaceutical compositions containing them | |
AU5123396A (en) | Pharmaceutical composition containing sucralfate | |
AU5155096A (en) | Pharmaceutical composition | |
GB9519667D0 (en) | Pharmaceutical composition | |
AU7904998A (en) | Pharmaceutical composition containing peptichemio | |
AU5274096A (en) | Pharmaceutical compositions | |
AU2531295A (en) | Pharmaceutical composition | |
AU689366B2 (en) | Sucralfate preparation | |
GB9502695D0 (en) | Pharmaceutical composition | |
GB9525194D0 (en) | Pharmaceutical composition | |
AU1172097A (en) | Pharmaceutical composition containing trehalose | |
AU3710695A (en) | Quinolonylcarboxyerythromycin derivatives and pharmaceutical compositions containing them | |
AU6814496A (en) | Pharmaceutical composition | |
AU741226C (en) | Pharmaceutical composition | |
AU723097C (en) | Pharmaceutical composition | |
AU2002301776A1 (en) | Pharmaceutical Composition | |
AUPN175995A0 (en) | Pharmaceutical composition | |
AUPN674495A0 (en) | Pharmaceutical composition | |
AUPN060495A0 (en) | Pharmaceutical composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK5 | Application lapsed section 142(2)(e) - patent request and compl. specification not accepted |